Clinical trial
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 · Michael E. DeBakey VA Medical Center, U.S. Fed · Completed
Key facts
| NCT number | NCT00304369 |
|---|---|
| Title | Response of Clostridium Difficile Infection to Metronidazole Therapy |
| Official title | The Response of Clostridium Difficile Infection to Metronidazole Therapy |
| Lead sponsor | Michael E. DeBakey VA Medical Center, U.S. Fed |
| Collaborators | Baylor College of Medicine |
| Status | Completed |
| Study type | Observational |
| Conditions | Clostridium Enterocolitis, Pseudomembranous Colitis, Antibiotic-Associated Colitis |
| Intervention type | Drug |
| Interventions | Metronidazole |
| Enrollment | 290 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Mar 17, 2006 |
| Last update posted | Feb 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: